How many studies have been conducted on Glial Cell Line Derived Neurotrophic Factor?

BiohacksAI has indexed 300 PubMed studies on Glial Cell Line Derived Neurotrophic Factor. 18% of studies involve human subjects.

What are the main research areas for Glial Cell Line Derived Neurotrophic Factor?

The primary research domains for Glial Cell Line Derived Neurotrophic Factor are 🧠 Learning, 🧠 Neuroprotection, 🌤️ Mood & Depression. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Glial Cell Line Derived Neurotrophic Factor

The founding member of the glial cell line-derived neurotrophic factor family. It was originally characterized as a NERVE GROWTH FACTOR promoting the survival of MIDBRAIN dopaminergic NEURONS, and it has been studied as a potential treatment for PARKINSON DISEASE.

300+ PubMed studies analyzed · Evidence Score: 44.9

Research Domains

Glial Cell Line Derived Neurotrophic Factor has been studied across 26 research domains including 🧠 Learning, 🧠 Neuroprotection, 🌤️ Mood & Depression, 🧠 Focus & Attention, 🔬 Oncology. The primary research focus is 🧠 Learning with 43% of studies addressing this area.

Loading evidence profile...

This evidence profile for Glial Cell Line Derived Neurotrophic Factor is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.